About
Pricing
FAQs
Providers
Trials
Blog
Login
Get started
Finding studies
Search
Narrow
Order
Status
Recruiting
Not yet recruiting
Active, not recruiting
Enrolling by invitation
Completed
Terminated
Phase
Early phase 1
Phase 1
Phase 1–2
Phase 2
Phase 2–3
Phase 3
Phase 4
Not applicable
Who can join
Healthy volunteers too
Searching
1–20 of 2,141
Completed
Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes
HBV infection is a dynamic process with complex interactions between virus replication and the host's immune response.
NCT05446532
·
Sabadell, Barcelona
Completed
A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D
This is a multicenter, open-label, randomized clinical trial to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination with Tenofovir Compared to…
NCT03546621
·
Hamburg and 14 others
Completed
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
We propose a largely retrospective study with short-term prospective follow-up in a subgroup of patients who have not yet been treated with 48 weeks of entecavir following partial…
NCT00704106
·
Palo Alto, California and 5 others
Completed
Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong
Globally, hepatitis B virus (HBV) infection is the most common form of chronic hepatitis.
NCT02443233
·
Hong Kong, Hong Kong
Not yet recruiting
A Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) Participants
This is a clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of AHB-121 injection in healthy and chronic hepatitis B participants.
NCT07884864
·
Shanghai, Shanghai Municipality
Not yet recruiting
Study of Long Non-coding RNA SNHG15 as a Novel Biomarker in HBV Associated HCC
In this study, the investigators will detect the expression of HBV-related HCC biomarker lncRNA SNHG15 in tumor tissues and peripheral blood, to explore the specific molecular…
NCT05840133
Not yet recruiting
The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms
The goal of this qualitative study is to explore the impact of antiviral treatment, or none, for chronic hepatitis B virus on the non-clinical (social) harms experienced by…
NCT07053449
Completed
Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B
The purpose of this study is to determine the optimal treatment duration of antiviral therapy for chronic hepatitis B.
NCT00291616
·
Seoul, Chongno-gu
Unknown
Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
The response to vaccination for hepatitis is reduced in patients with HIV infection.
NCT00451984
·
Aalborg and 1 other
Completed
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
Background: \- National Cancer Institute Protocol 04-C-N191, also known as the Costa Rica Vaccine Trial, was a double-blind controlled study of the effectiveness of an…
NCT01086709
·
San José
Terminated
A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma
The purpose of this study is to determine the superiority of inhibitory effects and safety of Menatetrenone (E0167) on recurrence in patients with hepatocellular carcinoma.
NCT00165633
·
Fukuoka, Fukuoka and 29 others
Completed
A Randomized Trial of Vaccine Adherence in Young Injection Drug Users
The purpose of this study is to compare the effects of (a) immunization setting and (b) outreach worker support on young injection drug users' (IDU) adherence to a multiple dose…
NCT00244374
·
San Francisco, California
Completed
The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines
At the time of the present study, the necessity for booster vaccinations for the prevention of hepatitis B(HB) 15 years post-vaccination in the group of young adults who have…
NCT00792610
·
Taipei
Completed
A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B
Tenofovir Disoproxil Fumarate is a nucleos(t)ide analogue that inhibits Hepatitis B Virus (HBV) growth, and is marketed in Japan with an indication for inhibition of HBV growth in…
NCT03258710
·
Aichi and 17 others
Completed
Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB
Treatment with a nucleoside analogue and subsequent viral decline has shown to partially restore immune hyporesponsiveness in chronic hepatitis B patients.
NCT01532843
·
Shanghai and 3 others
Unknown
Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis
HBV related Liver disease is a common medical problem in China.
NCT01728688
·
Xi'an, Shaanxi
Completed
A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection
The purpose of this study is to evaluate the antiviral activity and safety of tenofovir disoproxil fumarate (TDF) in Asian-American adults (self-reported Asian descent, living in…
NCT00736190
·
Fountain Valley, California and 20 others
Not yet recruiting
Antiviral Therapy in Infants With HBV Infection
This study was a multicenter, prospective randomized controlled clinical study.
NCT06503796
·
Beijing
Completed
Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis B
The aim of the study was to evaluate the consistency between liver biopsy and Liver Stiffness Measurement (LSM) for fibrosis and controlled attenuation parameter (CAP) for…
NCT06573190
·
Ankara
Not yet recruiting
The Effect of Hot Foot Bath on Sleep Quality and Fatigue
This study will be conducted to investigate the effects of hot foot baths on patients' sleep quality and fatigue severity levels.The study will be conducted in the…
NCT06864923
Back
1
2
3
···
108
1 / 108
Next
Data from
ClinicalTrials.gov
Terms
